Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA023923 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA023923, RRID:AB_1855783
- Product name
- Anti-PRR11
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human PRR11, Gene description: proline rich 11, Alternative Gene Names: FLJ11029, Validated applications: WB, IHC, Uniprot ID: Q96HE9, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer
Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients
miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer
Olsson Hau S, Wahlin S, Cervin S, Falk V, Nodin B, Elebro J, Eberhard J, Moran B, Gallagher W, Karnevi E, Jirström K
The Journal of Pathology: Clinical Research 2021;8(1):65-77
The Journal of Pathology: Clinical Research 2021;8(1):65-77
Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients
Zhan Y, Wu X, Zheng G, Jin J, Li C, Yu G, Li W
World Journal of Surgical Oncology 2020;18(1)
World Journal of Surgical Oncology 2020;18(1)
miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
Cai C, He H, Duan X, Wu W, Mai Z, Zhang T, Fan J, Deng T, Zhong W, Liu Y, Zhong W, Zeng G
Oncology Reports 2018
Oncology Reports 2018
The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
Chen Y, Cha Z, Fang W, Qian B, Yu W, Li W, Yu G, Gao Y
Oncotarget 2015;6(24):20419-20433
Oncotarget 2015;6(24):20419-20433
PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer
Xie K, Song Z, Liu W, Xiao Y, Zhang M, Luo Y, Yuan W, Xu Y, Yu G, Hu Y
PLOS ONE 2015;10(8):e0128943
PLOS ONE 2015;10(8):e0128943
No comments: Submit comment
No validations: Submit validation data